Search - tctmd.com

Displaying 461 - 480 of 2080

Sort: Relevancy | Date

Presentation TCT 2021

The Slippery Slope of "Too Much RV Dysfunction for TTVR" (Lessons From Surgery)

Presenter: Paul A. Grayburn

November 04, 2021

Presentation TCT 2021

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

TCT 566: Residual Left Atrial Appendage Leak Following Percutaneous Left Atrial Appendage Occlusion: An Arising Problem of The Emerging Procedure

Presenter: Chanavuth Kanitsoraphan

November 04, 2021

Presentation TCT 2021

Identification and Management of Patients at High Risk for Conduction Abnormalities

Presenter: Azeem Latib

November 04, 2021

News Conference News TCT 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

Todd Neale

November 04, 2021

Presentation TCT 2021

Don't Trip on the Wires: Managing Pacemaker Leads During TTVR

Presenter: Neil P. Fam

November 04, 2021

Presentation TCT 2021

TCT 565: Left Atrial Intramural Hematoma

Presenter: Aditya Kesari

November 04, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

Transcatheter Tricuspid Valve Replacement: Overview of Current Clinical State

Presenter: Molly Szerlip

November 04, 2021

Presentation TCT 2021

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

Presenter: Kristen Brown

November 04, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

Presenter: Ahmed El Shaer

November 04, 2021

Presentation TCT 2021

CLASP

Presenter: Molly Szerlip

November 04, 2021

Presentation TCT 2021

Triluminate

Presenter: Paul Sorajja

November 04, 2021

Presentation TCT 2021

Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations

Presenter: Jason Rogers

November 04, 2021

Presentation TCT 2021

TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI

Presenter: Michael Chiang

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles J. Davidson

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles Davidson

November 04, 2021

Presentation TCT 2021

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Presenter: Michael A. Weber

November 04, 2021

Presentation TCT 2021

Triluminate Registry: Lessons Learned for TEER Trial Design

Presenter: Georg Nickenig

November 04, 2021

Advertisement

The Slippery Slope of "Too Much RV Dysfunction for TTVR" (Lessons From Surgery)

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

TCT 566: Residual Left Atrial Appendage Leak Following Percutaneous Left Atrial Appendage Occlusion: An Arising Problem of The Emerging Procedure

Identification and Management of Patients at High Risk for Conduction Abnormalities

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

Don't Trip on the Wires: Managing Pacemaker Leads During TTVR

TCT 565: Left Atrial Intramural Hematoma

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Transcatheter Tricuspid Valve Replacement: Overview of Current Clinical State

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

CLASP

Triluminate

Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations

TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Triluminate Registry: Lessons Learned for TEER Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content